Stem Cells and Exosomes: What Is Approved, What Is Actually Injected, and What the Trials Show
A clinical account of commercial cell and exosome therapy — why the transplant literature does not transfer to a longevity clinic infusion, why 'stromal' replaced 'stem', and a concrete checklist for evaluating an offer.
Sunday, September 27, 2026 1 view
About This Tutorial
A clinical account of commercial cell and exosome therapy — why the transplant literature does not transfer to a longevity clinic infusion, why 'stromal' replaced 'stem', and a concrete checklist for evaluating an offer.
Tutorials Are a Paid Feature
Interactive tutorials with quizzes and score tracking are available to Practitioner members and above. Sign in to try one tutorial for free!
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe: